Biofrontera Inc. (BFRI) Misses Q1 EPS by 20c

Biofrontera Inc. (NASDAQ: BFRI) reported Q1 EPS of ($0.28), $0.20 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $8.7 million versus the consensus estimate of $11.1 million.

For earnings history and earnings-related data on Biofrontera Inc. (BFRI) click here.

You May Also Be Interested In

• Okta upgraded as AI security opportunity boosts outlook
• Sutro Biopharma Inc. (STRO) Misses Q2 EPS by 13c
• Medicis Pharmaceutical Corp. (MRX) Tops Q2 EPS by 39c